InvestorsHub Logo
icon url

CrashOverride

05/30/23 11:00 AM

#596994 RE: Poor Man - #596987

None of the recent financings involved dilution.

If you are unhappy then it could be time to sell. Your wife might be happy owning MRK which may benefit from DCVax in a future partnership.
icon url

dennisdave

05/30/23 1:32 PM

#597033 RE: Poor Man - #596987

from Seeking Alpha article Oct 8, 2022

if this company did things the normal way, then this data would make for a superb investment. But they don't do anything in the normal way, so I don't know. I can interpret the data, I can understand that the people behind the data have excellent pedigree. I cannot for the life of me interpret what NWBO is going to do. And that, my friends, remains the problem.

That pretty much sums things up
icon url

scotty3371

05/31/23 3:20 AM

#597153 RE: Poor Man - #596987

20 years of erosion.

Sadly this is a biotechnology company that has now moved their narrative from submission and approval to spoofing.

Closing in on three years since data lock. Pathetic.